GeneralConnection.com ➔ Dictionary
Dictionary Search

vasomotor

Synonyms

Adjective

1. constriction

2. dilation, dilatation

Usage
FDA says "study may proceed" for Vistagen's refisolone nasal spray for vasomotor symptoms - Contemporary OB/GYN
Vistagen Receives FDA “Study May Proceed” Letter Under its Refisolone IND Application, Enabling Further Phase 2 Clinical Development for the Treatment of Vasomotor Symptoms (Hot Flashes) due to Menopause - BioSpace
Neurokinin receptor antagonists for vasomotor symptoms: from KNDy neurons to clinical translation - Nature
Elinzanetant: Advancing Treatment for Vasomotor Symptoms - Pharmacy Times
Elinzanetant for Vasomotor Symptoms from Endocrine Therapy for Breast Cancer - NEJM
Lynkuet (elinzanetant) for the Treatment of Vasomotor Symptoms Due to Menopause - Rheumatology Advisor
How African American Patients Are Affected By Vasomotor Symptoms - Patient Care Online
U.S. approval of a new hormone-free treatment option for moderate to severe vasomotor symptoms due to menopause - Bayer
Risk factors, management and consequences of severe menopausal vasomotor symptoms - Nature
Pathophysiology of Vasomotor Symptoms in Menopause - Patient Care Online
Pooled Safety Analysis Supports Elinzanetant for Vasomotor Symptoms Through 52 Weeks - Patient Care Online
Fezolinetant shows significant real-world improvements in vasomotor symptoms, sleep - Contemporary OB/GYN
Pathophysiology of Vasomotor Symptoms in Menopause - Contemporary OB/GYN
Closing the Gap: Elinzanetant Demonstrates Efficacy for Vasomotor Symptoms in African American Women - Contemporary OB/GYN
Elinzanetant Demonstrates Rapid and Sustained Efficacy in Reducing Vasomotor Symptoms Across OASIS Clinical Trials - Pharmacy Times
Special Report: Managing vasomotor symptoms in menopause - Contemporary OB/GYN
Lisa Larkin, MD, on the Importance of Recognizing and Managing Vasomotor Symptoms in Menopause - Patient Care Online
Elinzanetant Reduces Postmenopausal Sleep Disturbances Independent of Improvements in Vasomotor Symptoms - Medscape
FDA Approves Elinzanetant as First Nonhormonal Therapy for Menopause Vasomotor Symptoms - Pharmacy Times
Estetrol Improves Vasomotor Symptoms With No BP Effects - Medscape
EU approval for new hormone-free treatment option for vasomotor symptoms associated with menopause or caused by endocrine therapy for breast cancer - Bayer
FDA approves elinzanetant (Lynkuet) for vasomotor menopausal symptoms - Contemporary OB/GYN
Vasomotor Symptoms Are Linked to Vascular and Cartilage Structural Changes in Postmenopausal Women - Wiley
Vasomotor Symptoms and Adjuvant Endocrine Therapy: Burden and Available Evidence - EMJ
Elinzanetant Shows Strong 52-Week Safety for Vasomotor Symptoms: James Simon, MD - The American Journal of Managed Care® (AJMC®)
Impact of Vasomotor Symptoms on Patient Quality of Life - Patient Care Online
Elinzanetant for Vasomotor Symptoms From Endocrine Therapy for Breast Cancer - The ASCO Post
Four Studies Build Evidence for Elinzanetant as a Safe, Effective Nonhormonal Option for Menopausal Vasomotor Symptoms - Patient Care Online
FDA extends review period for Bayer's elinzanetant for vasomotor symptoms - Contemporary OB/GYN
Noema Pharma Announces Phase 2a Study Results with - GlobeNewswire
New nonhormonal therapies transform hot flash treatment in menopause - Contemporary OB/GYN
FDA Approves Elinzanetant, a Hormone-Free Option for Hot Flashes in Menopause - The American Journal of Managed Care® (AJMC®)
Special Report: How neurokinin receptor antagonists are reshaping the VMS treatment landscape - Contemporary OB/GYN
Hormone Therapy Does Not Increase Cardiovascular Disease Risk in Younger Postmenopausal Women - Northwestern University
FDA Approves Elinzanetant for Moderate-to-Severe Vasomotor Symptoms of Menopause: Daily Dose - Patient Care Online
New menopause drug to target hot flashes without hormones gets FDA approval - ABC7 Chicago
NHS to offer fezolinetant for menopause‑related hot flushes and night‑sweats - PharmaTimes
Bayer receives FDA approval for non-hormonal menopause therapy - BioPharma Dive
Special Report: Future research outlook - Contemporary OB/GYN
Fezolinetant Can Reduce Menopause Symptoms in Women Who Cannot or Will Not Take Hormone Therapy - American Academy of Family Physicians | AAFP
Association between modified mediterranean diet score and menopause-specific quality of life and symptoms: a cross-sectional study | Scientific Reports - Nature
FDA Green-Lights Elinzanetant, First Dual NK-1/NK-3 Antagonist, for Moderate to Severe Vasomotor Symptoms of Menopause - Patient Care Online
New Data Show Elinzanetant Is a Safe, Well-Tolerated Nonhormonal Therapy for Menopausal Vasomotor Symptoms - Pharmacy Times
How New Pathways Are Easing Vasomotor Symptoms in Breast Cancer Care - Contemporary OB/GYN
ACTG Launches Critical Study Evaluating Hormone Therapy for Women Living with HIV in the Menopause Transition - The Manila Times
Special Report: Identifying gaps in care - Contemporary OB/GYN
Elinzanetant recommended for approval in EU as treatment of moderate to severe vasomotor symptoms - Bayer
Elinzanetant Eases Vasomotor Symptoms in HR+ Breast Cancer - Docwire News
Navigating Vasomotor Symptoms From Endocrine Therapy in Breast Cancer Treatment - Contemporary OB/GYN
Elinzanetant demonstrates favorable safety profile in menopausal women, with James A. Simon, MD - Contemporary OB/GYN
New study may offer hope to women suffering menopausal hot flashes, night sweats - Medical Xpress
Special Report: Recent advancements in pharmacologic and nonpharmacologic treatment options - Contemporary OB/GYN
Plant-Based Estrogen Diminished Menopause Symptoms - MedPage Today
VisualAbstract: Elinzanetant Effectively Reduces Vasomotor Symptoms from Endocrine Therapy for Breast Cancer - 2 Minute Medicine
Dr Cardoso on the Effect of Elinzanetant on Vasomotor Symptoms in HR+ Breast Cancer - OncLive
Elinzanetant Shows Consistent Efficacy, Safety, and Sleep Benefits Across Studies - The American Journal of Managed Care® (AJMC®)
Menopause drug reduces hot flashes by more than 70%, international clinical trial finds - Medical Xpress
Elinzanetant significantly reduces frequency of moderate to severe vasomotor symptoms associated with endocrine therapy for breast cancer in Phase III OASIS-4 study - Bayer
Nitroglycerin withdrawal increases endothelium-dependent vasomotor response to acetylcholine - JACC Journals
Novel Nonhormonal Drug Approved for Menopause Hot Flashes - MedPage Today
Elinzanetant Reduces Frequency, Severity of VMS in Differing Female Populations - Pharmacy Times
AbCellera Announces First Patients Dosed in Phase 2 Portion of its Phase 1/2 Clinical Trial of ABCL635 for the Treatment of Vasomotor Symptoms Due to Menopause - Yahoo Finance
newsGP - Vasomotor symptoms key to perimenopause diagnosis - Royal Australian College of General Practitioners (RACGP)
Elinzanetant found to reduce VMS from endocrine therapy for breast cancer - Contemporary OB/GYN
Elinzanetant reduces hot flashes in menopause - News-Medical
OASIS-4 Trial: Elinzanetant Reduces Frequency of Vasomotor Symptoms Related to Endocrine Therapy for HR-Positive Breast Cancer - Patient Care Online
Elinzanetant Demonstrates Clinically Meaningful Reductions in Menopausal Vasomotor Symptoms, Meta-analysis Shows - Patient Care Online
Phase III OASIS-4 Trial Shows Elinzanetant Significantly Reduces Endocrine Therapy–Related Vasomotor Symptoms in Patients with HR-Positive Breast Cancer - Applied Clinical Trials Online
Vasomotor Symptoms of Menopause: Facts At-a-Glance for Primary Care - Patient Care Online
How a Mediterranean diet helps women manage menopausal symptoms - News-Medical
Acta Obstetricia et Gynecologica Scandinavica | NFOG Women's Health Journal | Wiley Online Library - Wiley
Narcolepsy Patients Show Enhanced Brain Waste Clearance Through Compensatory Vasomotor Activity - Sleep Review
Lisa Larkin, MD, on the Impact of Elinzanetant on Menopause Management - Patient Care Online
An update on the use of non-hormonal therapies for vasomotor symptoms of menopause - Royal Australian College of General Practitioners (RACGP)
Study: Elinzanetant cuts vasomotor symptoms in women with breast cancer on endocrine therapy - Medical Xpress
Heart Risks of Hormone Therapy for Hot Flashes Double Starting at This Age - MedPage Today
With FDA nod, Bayer's Lynkuet enters US market for nonhormonal menopause symptom meds - Fierce Pharma
Elinzanetant Approved for Menopausal Hot Flashes by FDA - Conexiant
Fezolinetant shows real-world promise for menopause symptoms - PharmaTimes
OASIS-4 trial: Efficacy and safety of elinzanetant for vasomotor symptoms associated with adjuvant endocrine therapy in women with breast cancer - EMJ
How Can Women Control Their Weight During Menopause? - The American Journal of Managed Care® (AJMC®)
MHRA approves elinzanetant to treat moderate to severe vasomotor symptoms (hot flushes) caused by menopause - GOV.UK
FDA Extends Review Period for Bayer’s Elinzanetant for Moderate to Severe Menopausal Symptoms - Pharmaceutical Executive
You know VMS is underdiagnosed. But are you part of the problem? - MDLinx
Many physicians still consider VMS to be transient and inconsequential, but new research suggests otherwise—are you all caught up? - MDLinx
AbCellera begins Phase II ABCL635 trial for menopause-related VMS - Clinical Trials Arena
Fezolinetant for treatment of moderate-to-severe vasomotor symptoms associated with menopause (SKYLIGHT 1): a phase 3 randomised controlled study - The Lancet
Singapore Approves Astellas’ VEOZA™ (Fezolinetant) for Moderate to Severe Menopausal Vasomotor Symptoms - BioPharma APAC
‘Ignoring hot flushes is wrong’: study challenges assumptions about perimenopause symptoms - The Guardian
Bayer drug could ease side effects of common breast cancer treatment, detailed data show - BioPharma Dive
Bayer Receives First Global Approval for Lynkuet to Treat Menopause Vasomotor Symptoms - Femtech Insider
Bayer scores first approval for hormone-free menopause drug Lynkuet in UK - Fierce Pharma
2023 Menopause Society Annual Meeting Highlights Vasomotor Symptoms Treatment - Endocrinology Advisor
Bayer Elinzanetant recommended for nod in EU for moderate to severe vasomotor symptoms - Medical Dialogues
Elinzanetant for Vasomotor Symptoms from Endocrine Therapy for Breast Cancer - University College Dublin
Elinzanetant Excels in Phase 3 Study for Vasomotor Symptom Relief - The American Journal of Managed Care® (AJMC®)
Abcellera gains Canadian clearance for phase I study of ABCL-635 for vasomotor symptoms in menopause - BioWorld News
FDA accepts elinzanetant NDA for vasomotor symptoms in menopause - Contemporary OB/GYN
Fezolinetant significantly reduces vasomotor symptoms in post-menopausal women - 2 Minute Medicine
Best nonhormone methods for managing vasomotor symptoms - Contemporary OB/GYN
Foreign Language Equivalents
Foreign Language Equivalents of 'vasomotor'
Language Equivalent   Language Equivalent
French    Spanish
Misspellings - Typos
,   vssomotor,   casomotor,   asomotor,   vasomptor,   vvasomotor,   vasonotor,   vasomootr,   vasomtor,   vasmotor,   vasomotpr,   vaosmotor,   vasoomotor,   vasomoyor,   vasootor,   vasomootor,   vassomotor,   vasomotorr,   vasimotor,   vsomotor,   vasomottor,   vasomoror,   vasomotoe,   vasomitor,   vaaomotor,   vaso,otor,   vaasomotor,   vadomotor,   vasomoter,   vasomotro,   vasomotot,   vasomotr,   basomotor,   vasomoor,   vasmootor,   vasomotir,   vasoomtor,   vasomoto,   vasommotor,   vasomotoor,   vaspmotor,   vsaomotor,   vasomtoor,   vaomotor,   avsomotor
Words Starting with Letter - 'A'
a a battery a billion
a bit a bit much a capella singing
a cappella singing a couple of a few
a fortiori a good deal a great deal
a horizon a hundred a hundred and one
a hundred thousand a hundred times a kempis
a la carte a la mode a level
a little a lot a million
Go to Page 1              Go to Page 2 »   
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z